Condition: Multiple Sclerosis · Sponsor: Rennes University Hospital
In this study, we propose, for the first time, to test the safety and the potential efficacy of repeated allogenic Adipose tissue-derived Mesenchymal Stromal Cells IT injections in Primary Progressive Multiple Sclerosis patients.
This description comes directly from the study's public registry record.
Laure MICHEL, Pr · 0299284321 · laure.michel@chu-rennes.fr
Marie-Laure GERVAIS, PhD · 0299282555 · marie-laure.gervais@chu-rennes.fr
Always discuss trial participation with your own doctor first.
| APHP Henri Mondor | Créteil, France | Active Not Recruiting |
| CHU Rennes | Rennes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06592703